Using 1,456 SNPs across 60 genetically diverse inbred strains (median minor allele frequency 0.32; median pairwise strain difference 42.8%), the authors found ~44% of marker pairs within 1 Mb in LD (pFET < 0.001; BenjaminiβHochberg FDR = 0.09), decaying to ~1% only beyond 20 Mb. Randomized-location and randomized-allele controls showed no such excess (Figure 2).
The most decisive experiment: in recombinant-inbred (RI) lines, LD-domain regions showed far fewer recombinant lines than expected (69 observed vs 116 expected, p = 3Γ10β7), while nondomains matched expectation (83 vs 88, p = 0.57). Crucially, single-generation recombination rates were equivalent in domains vs nondomains (~0.5 vs ~0.55 cM/Mb) β so LD reflects lack of recombinant survival, not reduced recombination (Table 1).
The Chromosome 1 domain (167.2β174.2 Mb; 119 genes) contained 21/35 genes of an Ingenuity immune-response pathway (hypergeometric p = 10β25) plus a Myc-regulated subnetwork; distant LD interactions fit a scale-free distribution f(n) = 0.79nβ1.73, inconsistent with Poisson expectation (Figure 7).
Strengths: multiple independent lines of evidence (randomization controls, RI-line selection tests, replication with two denser SNP panels, GO enrichment with multiple-testing correction, and the charmingly falsifiable prediction that blind mice are picked first β supporting "eye morphogenesis" enrichment). Weaknesses: (1) the SNP panel derives from few strains, potentially limiting representation of mouse diversity (authors acknowledge this); (2) domain boundaries are parameter-sensitive (30 Dβ²/q combinations tested, but only one genome is sampled); (3) unadjusted pFET < 0.001 thresholds across ~1M pairs risk inflated FDR despite correction claims; (4) selection pressures are laboratory-inbreeding-specific β the authors honestly note domain edges may reflect lab conditions, not general evolution; (5) the leap from mouse LD domains to conserved mammalian/human functional organization is inference, not demonstrated (Discussion).
What would disprove the conclusion: showing LD domains persist under randomized marker sets, fail to replicate with denser panels, show no GO/pathway enrichment with modern annotations, or vanish in outbred populations with recombination measured directly.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.